In a recent study on two complementary mouse models of AD, intranasal administration of DHA reduced cognitive deterioration and Tau hyperphosphorylation (histopathological hallmark of AD) via inhibition of the c-Jun N-terminal kinase (JNK) [94]. The gene discussed is MAPT; the disease is Alzheimer disease.